CN Patent

CN103893765A — 包含二氢吡啶钙通道拮抗剂的药物组合物及其制备方法

Assigned to Pharmathen SA · Expires 2014-07-02 · 12y expired

What this patent protects

本发明涉及固体剂型制剂，其包含治疗有效量的二氢吡啶钙通道拮抗剂如乐卡地平或其盐以及用于提高生物利用率和提高溶解性的胶体二氧化硅如Aerosil TM ；以及通过湿法制粒的其制备方法。

USPTO Abstract

本发明涉及固体剂型制剂，其包含治疗有效量的二氢吡啶钙通道拮抗剂如乐卡地平或其盐以及用于提高生物利用率和提高溶解性的胶体二氧化硅如Aerosil TM ；以及通过湿法制粒的其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103893765A
Jurisdiction
CN
Classification
—
Expires
2014-07-02
Drug substance claim
No
Drug product claim
No
Assignee
Pharmathen SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.